These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6202980)

  • 41. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
    Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
    J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of the new cardiotonic agent loprinone hydrochloride (E-1020) on left ventricular diameter in normal and experimental heart failure dogs and its action potential characteristics in isolated guinea pig cardiac muscles and sinus nodes].
    Ohhara H; Sawada K; Ogawa T; Takeda M; Igarashi T
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):421-33. PubMed ID: 1398339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular actions of DPI 201-106, a novel cardiotonic agent.
    Salzmann R; Scholtysik G; Clark B; Berthold R
    J Cardiovasc Pharmacol; 1986; 8(5):1035-43. PubMed ID: 2429077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
    von Meel JC
    Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.
    Carroll JD; Lang RM; Neumann AL; Borow KM; Rajfer SI
    Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
    Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
    J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744).
    Micheletti R; Mattera GG; Rocchetti M; Schiavone A; Loi MF; Zaza A; Gagnol RJ; De Munari S; Melloni P; Carminati P; Bianchi G; Ferrari P
    J Pharmacol Exp Ther; 2002 Nov; 303(2):592-600. PubMed ID: 12388640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological actions of APP 201-533, a novel cardiotonic agent.
    Salzmann R; Bormann G; Herzig JW; Markstein R; Scholtysik G
    J Cardiovasc Pharmacol; 1985; 7(3):588-96. PubMed ID: 2410694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.
    Van de Water A; d'Aubioul J; Van Gerven W; de Chaffoy de Courcelles D; Freyne E; Xhonneux R; Reneman RS; Janssen PA
    Arch Int Pharmacodyn Ther; 1992; 316():60-74. PubMed ID: 1530374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of volatile anesthetic-induced depression of myocardial contractility by extracellular calcium also enhances left ventricular diastolic function.
    Pagel PS; Kampine JP; Schmeling WT; Warltier DC
    Anesthesiology; 1993 Jan; 78(1):141-54. PubMed ID: 8424547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular effects of intravenous pentazocine and cyclazocine in conscious, curarized-conscious, and anesthetized dogs.
    Küçukhüseyin C
    J Basic Clin Physiol Pharmacol; 2003; 14(3):235-55. PubMed ID: 14964736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines].
    Hagen V; Rumler A; Klauschenz E; Hagen A; Heer S; Faust G; Mitzner R
    Pharmazie; 1990 Apr; 45(4):240-1. PubMed ID: 2381972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs.
    Pagel PS; Hettrick DA; Lowe D; Gowrie PW; Kersten JR; Bosnjak ZJ; Warltier DC
    Eur J Pharmacol; 1998 May; 348(2-3):213-21. PubMed ID: 9652336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.